1. Home
  2. KMDA vs ALTI Comparison

KMDA vs ALTI Comparison

Compare KMDA & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • ALTI
  • Stock Information
  • Founded
  • KMDA 1990
  • ALTI 2020
  • Country
  • KMDA Israel
  • ALTI United States
  • Employees
  • KMDA N/A
  • ALTI N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • ALTI Investment Managers
  • Sector
  • KMDA Health Care
  • ALTI Finance
  • Exchange
  • KMDA Nasdaq
  • ALTI Nasdaq
  • Market Cap
  • KMDA 394.4M
  • ALTI 402.9M
  • IPO Year
  • KMDA N/A
  • ALTI N/A
  • Fundamental
  • Price
  • KMDA $6.92
  • ALTI $3.93
  • Analyst Decision
  • KMDA Strong Buy
  • ALTI
  • Analyst Count
  • KMDA 2
  • ALTI 0
  • Target Price
  • KMDA $14.50
  • ALTI N/A
  • AVG Volume (30 Days)
  • KMDA 159.8K
  • ALTI 80.4K
  • Earning Date
  • KMDA 03-05-2025
  • ALTI 03-14-2025
  • Dividend Yield
  • KMDA N/A
  • ALTI N/A
  • EPS Growth
  • KMDA 124.29
  • ALTI N/A
  • EPS
  • KMDA 0.27
  • ALTI N/A
  • Revenue
  • KMDA $158,380,000.00
  • ALTI $246,970,000.00
  • Revenue This Year
  • KMDA $15.37
  • ALTI N/A
  • Revenue Next Year
  • KMDA $8.58
  • ALTI $11.83
  • P/E Ratio
  • KMDA $25.36
  • ALTI N/A
  • Revenue Growth
  • KMDA 4.52
  • ALTI 39.57
  • 52 Week Low
  • KMDA $4.74
  • ALTI $3.47
  • 52 Week High
  • KMDA $8.00
  • ALTI $7.25
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 50.80
  • ALTI 42.48
  • Support Level
  • KMDA $6.90
  • ALTI $3.89
  • Resistance Level
  • KMDA $7.56
  • ALTI $4.27
  • Average True Range (ATR)
  • KMDA 0.19
  • ALTI 0.18
  • MACD
  • KMDA -0.09
  • ALTI -0.01
  • Stochastic Oscillator
  • KMDA 15.95
  • ALTI 41.38

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.

Share on Social Networks: